When This Enzyme Fades, Fat Ages Faster
Body fat has a reputation problem — but it also ages, and often faster than the rest of us.
Adipose tissue — body fat — is among the most age-sensitive tissues in the human body. With age, fat doesn’t just accumulate differently; it changes character. Aging fat tissue loses its metabolic flexibility, begins secreting inflammatory signals, and contributes to conditions like insulin resistance and type 2 diabetes. Why this happens at a cellular level has been a persistent question in aging biology.
A team publishing in Aging Cell identified a key player: the enzyme Pck1, formally known as phosphoenolpyruvate carboxykinase 1. Pck1 is central to gluconeogenesis — the process by which the liver and other tissues produce glucose when food isn’t available. The new finding: Pck1 also plays a protective role specifically in fat cells. When its activity declines — as it naturally does with age — fat cells accumulate the hallmarks of cellular senescence more rapidly.
The zombie cell problem in fat tissue
Senescent cells are cells that have stopped dividing but refuse to die. Instead, they linger and secrete a damaging cocktail of inflammatory molecules — a phenomenon researchers call the SASP, or senescence-associated secretory phenotype. In fat tissue, this is particularly harmful: it disrupts local metabolism and sends damaging signals to surrounding organs. The new study shows Pck1 helps fat cells resist the molecular damage that triggers senescence in the first place.
When the researchers experimentally switched off Pck1 in fat cells, senescence accelerated visibly. Maintaining Pck1 activity, conversely, appeared to keep cells healthier for longer. This suggests that the metabolic slowdown associated with aging — reduced enzyme activity, lower energy flux — is not merely a consequence of aging, but a contributing cause. A feedback loop that compounds over time.
Metabolism and aging are the same story
The broader implication is that metabolic enzymes — proteins we primarily associate with energy and food processing — have a direct hand in how fast tissues age. This fits an emerging view in aging biology that metabolism and aging are not separate processes to be studied in isolation, but deeply entangled systems that regulate each other.
Whether Pck1 activity can be therapeutically maintained in aging humans remains unclear. The enzyme has wide-ranging metabolic functions, and boosting it without unintended consequences would not be straightforward. But the study adds a concrete mechanism to the question of why aging fat plays such a central role in disease — and that matters.